VIVAX | WLCVX | VIVAX / WLCVX | |
Total Expense Ratio | 0.17 | 1.00 | 17% |
Annual Report Gross Expense Ratio | 0.17 | 1.03 | 17% |
Fund Existence | 33 years | 29 years | - |
Gain YTD | 6.512 | 8.381 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 250000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 196B | 171M | 114,620% |
Annual Yield % from dividends | 2.06 | 1.25 | 164% |
Returns for 1 year | 7.90 | 4.22 | 187% |
Returns for 3 years | 25.93 | 12.10 | 214% |
Returns for 5 years | 68.56 | 38.95 | 176% |
Returns for 10 years | 114.64 | 21.27 | 539% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICEWX | 45.64 | 0.43 | +0.95% |
NYLI Epoch International Choice Class C | |||
NGJFX | 18.90 | 0.06 | +0.32% |
Nuveen Global Real Estate Securities R6 | |||
MWECX | 38.32 | 0.12 | +0.31% |
MFS Global Equity C | |||
JDEAX | 46.85 | -0.11 | -0.23% |
JPMorgan US Research Enhanced Equity A | |||
HWVAX | 11.99 | -0.13 | -1.07% |
Hotchkis & Wiley Sm Cp Divers Val A |